Skip to content

Prevention of low blood pressure with ondansetron for spinal anesthesia in patients undergoing cesarean section: placebo-controlled clinical trial

Hypotension prophylaxis with ondansetron for spinal anesthesia in patients undergoing cesarean section: placebo-controlled clinical trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-5y3w37m
Enrollment
Unknown
Registered
2021-05-28
Start date
2019-09-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant women, hypotension prophylaxis during cesarean section

Interventions

In the intervention group, 95 patients will be administered 4 mg of intravenous ondansetron (diluted in 0.9% NaCl saline to a volume of 10 ml), 5 minutes before spinal anesthesia for cesarean section,
D017294
D007022

Sponsors

Hospital das Clínicas
Lead Sponsor
Cristália Produtos Químicos Farmacêuticos LTDA
Collaborator

Eligibility

Sex/Gender
Female
Age
15 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients older than 15 years, undergo spinal anesthesia for cesarean delivery and surgical risk ASA II or III (American Society of Anesthesiology Classification)

Exclusion criteria

Exclusion criteria: Long QT syndrome, pacemaker use, ondansetron allergy, patients using ondansetron in the last 24 hours and obstetric emergencies

Design outcomes

Primary

MeasureTime frame
To compare between the intervention group and the control group the incidence of hypotension after spinal anesthesia until the birth of the fetus, measured by multiparametric monitor (Alfamed VITA400). Measurements are taken every 3 minutes. Hypotension is defined as any decrease in diastolic or systolic blood pressure (measured in mmHg) from preoperative baseline values (mean of the patient's last two measurements during hospitalization).

Secondary

MeasureTime frame
To compare the mean intraoperative blood pressure (in mmHg) and heart rate (in beats per minute), recorded every 3 min between groups. Compare the incidence of intraoperative nausea, vomiting and itching between the two groups. Compare vasopressor consumption (in milligrams) between the two groups.

Countries

Brazil

Contacts

Public ContactSérgio Menezes

Hospital das Clínicas

sergiovdsm@gmail.com+55-081-992161866

Outcome results

None listed

Source: REBEC (via WHO ICTRP)